Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 721-732 of 4,306
Drug study icon
CompletedNCT04922593

Relative Bioavailability of LY03010 Compared to Listed Drug

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT03741751

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In St Louis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Schizophrenia
Device study icon
Active Not RecruitingNCT04318977

rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Brno
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
Czechia, Germany
Sponsor
University of Regensburg
Condition
Schizophrenia
Behavioral study icon
CompletedNCT07111689

The Effect of Virtual Reality on Cognitive Skills in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Ankara
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Saglik Bilimleri Universitesi
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2021-003588-85

Individualized care with antipsychotics in patients suffering from schizophrenia spectrum disorders- How to conciliate plasma concentrations, clinical response and genetic factors ?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium
Sponsor
UCLouvain
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2004-000830-35

Maintenance of the clinical response with long-acting injectable Risperidone in patients with Schizophrenia or schizoaffective disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Italy
Sponsor
JANSSEN-CILAG
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2015-004483-11

Raloxifene Augmentation in Patients with a Schizophrenia spectrum Disorder to reduce symptoms and improve cognition

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium, Netherlands
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2016-000565-23

TAILOR - a randomized clinical trial: Tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or schizophreniform psychosis in ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Denmark
Sponsor
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.